共 30 条
A 1-day imported fire ant rush immunotherapy schedule with and without premedication
被引:20
作者:
Arseneau, April M.
[1
]
Nesselroad, Teresa D.
[1
]
Dietrich, Jeffrey J.
[1
]
Moore, Laura M.
[1
]
Nguyen, Steven
[1
]
Hagan, Larry L.
[1
]
Tankersley, Michael S.
[1
]
机构:
[1] San Antonio Mil Med Ctr, San Antonio, TX USA
关键词:
SYSTEMIC REACTIONS;
HONEYBEE VENOM;
DOUBLE-BLIND;
HYPERSENSITIVITY;
PRETREATMENT;
STINGS;
ANAPHYLAXIS;
REDUCTION;
EFFICACY;
D O I:
10.1016/j.anai.2013.08.021
中图分类号:
R392 [医学免疫学];
学科分类号:
100102 ;
摘要:
Background: Rush immunotherapy (RIT) schedules can expedite protection in individuals sensitive to imported fire ant (IFA) stings. Objective: To evaluate the safety and efficacy of 1-day RIT with IFA whole body extract (WBE) and determine the benefit of premedication with antihistamines and prednisone. Methods: Patients with systemic reactions to IFAs and evidence of specific IgE by skin test or serologic test started a 1-day RIT protocol without premedication. The 1-day RIT protocol consisted of a total of 10 injections every 30 to 60 minutes to achieve a 0.3-mL 1:100 (wt/vol) dose. A higher systemic reaction rate (SRR) prompted protocol revision to include a 3-day course of oral 20 mg of prednisone twice daily, 150 mg of ranitidine, and 10 mg of loratadine started 2 days before the 1-day RIT. Patients returned on days 8 and 15 to receive a 0.5 mL 1:100 (wt/vol) maintenance injection. The effectiveness of the RIT was evaluated with a sting challenge on approximately day 22. Results: Eighty of the 96 patients enrolled initiated the 1-day RIT. The first nonpremedicated group exhibited a SRR of 24.3% (9 of 37 patients), whereas the revised premedicated group had a SRR of 9.5% (4 of 42 patients; P = .07). The most severe reaction during RIT included dizziness, angioedema, and urticaria. Sting challenges on 53 patients resulted in 1 mild rhinitis reaction (efficacy, 98.1%). Conclusion: One-day RIT with IFA WBE for IFA hypersensitivity is efficacious. Although there was a trend with premedications to reduce SRRs during the RIT, safety data with premedication require confirmation in a larger trial. (C) 2013 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:562 / 566
页数:5
相关论文